Literature DB >> 8745410

Reconstitution of active octameric mitochondrial creatine kinase from two genetically engineered fragments.

M Gross1, M Wyss, E M Furter-Graves, T Wallimann, R Furter.   

Abstract

Creatine kinase (CK) has been postulated to consist of two flexibly hinged domains. A previously demonstrated protease-sensitive site in M-CK (Morris & Jackson, 1991) has directed our attempts to dissect mitochondrial CK (Mi-CK) into two protein fragments encompassing amino acids [1-167] and [168-380]. When expressed separately in Escherichia coli, the two fragments yielded large amounts of insoluble inclusion bodies, from which the respective polypeptides could be purified by a simple two-step procedure. In contrast, co-expression of the two fragments yielded a soluble, active, and correctly oligomerizing enzyme. This discontinuous CK showed nearly full specific activity and was virtually indistinguishable from native Mi-CK by far- and near-UV CD. However, the positive cooperativity of substrate binding was abolished, suggesting a role of the covalent domain linkage in the crosstalk between the substrate binding sites for ATP and creatine. The isolated C-terminal fragment refolded into a native-like conformation in vitro, whereas the N-terminal fragment was largely unfolded. Prefolded [168-380] interacted in vitro with [1-167] to form an active enzyme. Kinetic analysis indicated that the fragments associate rapidly and with high affinity (1/K1 = 17 microM) and then isomerize slowly to an active enzyme (k2 = 0.12 min-1; k-2 = 0.03 min-1). Our data suggest that the C-terminal fragment of Mi-CK represents an autonomous folding unit, and that the folding of the C-terminal part might precede the conformational stabilization of the N-terminal moiety in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8745410      PMCID: PMC2143346          DOI: 10.1002/pro.5560050216

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  20 in total

1.  Monoclonal antibody studies suggest a catalytic site at the interface between domains in creatine kinase.

Authors:  G E Morris; A J Cartwright
Journal:  Biochim Biophys Acta       Date:  1990-07-06

2.  Monoclonal antibody studies of creatine kinase. The ART epitope: evidence for an intermediate in protein folding.

Authors:  G E Morris
Journal:  Biochem J       Date:  1989-01-15       Impact factor: 3.857

3.  Function of M-line-bound creatine kinase as intramyofibrillar ATP regenerator at the receiving end of the phosphorylcreatine shuttle in muscle.

Authors:  T Wallimann; T Schlösser; H M Eppenberger
Journal:  J Biol Chem       Date:  1984-04-25       Impact factor: 5.157

4.  Kinetic properties of the octameric and dimeric forms of mitochondrial creatine kinase and physiological role of the enzyme.

Authors:  M E Trofimova; N S Moiseeva
Journal:  Biochem Int       Date:  1989-09

5.  Identification by protein microsequencing of a proteinase-V8-cleavage site in a folding intermediate of chick muscle creatine kinase.

Authors:  G E Morris; P J Jackson
Journal:  Biochem J       Date:  1991-12-15       Impact factor: 3.857

6.  Statistical analysis of enzyme kinetic data.

Authors:  W W Cleland
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

7.  Isotope exchange studies of the mechanism of the reaction catalyzed by adenosine triphosphate: creatine phosphotransferase.

Authors:  J F Morrison; W W Cleland
Journal:  J Biol Chem       Date:  1966-02-10       Impact factor: 5.157

8.  Chaperonins groEL and groES promote assembly of heterotetramers (alpha 2 beta 2) of mammalian mitochondrial branched-chain alpha-keto acid decarboxylase in Escherichia coli.

Authors:  R M Wynn; J R Davie; R P Cox; D T Chuang
Journal:  J Biol Chem       Date:  1992-06-25       Impact factor: 5.157

9.  Expression of active octameric chicken cardiac mitochondrial creatine kinase in Escherichia coli.

Authors:  R Furter; P Kaldis; E M Furter-Graves; T Schnyder; H M Eppenberger; T Wallimann
Journal:  Biochem J       Date:  1992-12-15       Impact factor: 3.857

10.  Sequence and structure of yeast phosphoglycerate kinase.

Authors:  H C Watson; N P Walker; P J Shaw; T N Bryant; P L Wendell; L A Fothergill; R E Perkins; S C Conroy; M J Dobson; M F Tuite
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

View more
  7 in total

1.  Fragment complementation of calbindin D28k.

Authors:  T Berggård; E Thulin; K S Akerfeldt; S Linse
Journal:  Protein Sci       Date:  2000-11       Impact factor: 6.725

2.  Conformational change in the C-terminal domain is responsible for the initiation of creatine kinase thermal aggregation.

Authors:  Hua-Wei He; Jun Zhang; Hai-Meng Zhou; Yong-Bin Yan
Journal:  Biophys J       Date:  2005-07-08       Impact factor: 4.033

Review 3.  Functional aspects of the X-ray structure of mitochondrial creatine kinase: a molecular physiology approach.

Authors:  U Schlattner; M Forstner; M Eder; O Stachowiak; K Fritz-Wolf; T Wallimann
Journal:  Mol Cell Biochem       Date:  1998-07       Impact factor: 3.396

4.  Control of protein splicing by intein fragment reassembly.

Authors:  M W Southworth; E Adam; D Panne; R Byer; R Kautz; F B Perler
Journal:  EMBO J       Date:  1998-02-16       Impact factor: 11.598

5.  Chaperone-like effect of the linker on the isolated C-terminal domain of rabbit muscle creatine kinase.

Authors:  Zhe Chen; Xiang-Jun Chen; Mengdie Xia; Hua-Wei He; Sha Wang; Huihui Liu; Haipeng Gong; Yong-Bin Yan
Journal:  Biophys J       Date:  2012-08-08       Impact factor: 4.033

6.  Reduction of cell lysate viscosity during processing of poly(3-hydroxyalkanoates) by chromosomal integration of the staphylococcal nuclease gene in Pseudomonas putida.

Authors:  Z L Boynton; J J Koon; E M Brennan; J D Clouart; D M Horowitz; T U Gerngross; G W Huisman
Journal:  Appl Environ Microbiol       Date:  1999-04       Impact factor: 4.792

7.  Protease digestion studies of an equilibrium intermediate in the unfolding of creatine kinase.

Authors:  T Webb; P J Jackson; G E Morris
Journal:  Biochem J       Date:  1997-01-01       Impact factor: 3.857

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.